{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:13:07Z","timestamp":1786997587785,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007824","name":"Soochow University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2413100"],"award-info":[{"award-number":["2023YFC2413100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.tracli.2024.11.008","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T18:22:21Z","timestamp":1732645341000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploration of HLA-matched platelet units in HLA-immunized PTR: A retrospective study of patients with hematological disorders"],"prefix":"10.1016","volume":"32","author":[{"given":"Yuanling","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juping","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2024.11.008_b0005","first-page":"83","article-title":"Prevention of platelet alloimmunization","volume":"211","author":"Slichter","year":"1986","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.tracli.2024.11.008_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0887-7963(88)70027-9","article-title":"Transfusion and bone marrow transplantation","volume":"2","author":"Slichter","year":"1988","journal-title":"Transfus Med Rev"},{"issue":"2","key":"10.1016\/j.tracli.2024.11.008_b0015","first-page":"247","article-title":"A mini-review on platelet refractoriness","volume":"90","author":"Rebulla","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2024.11.008_b0020","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/trf.13263","article-title":"Pretransplant platelet transfusion refractoriness is not associated with platelet nonengraftment in T-replete hematopoietic progenitor cell transplantation for hematologic malignancies","volume":"56","author":"Scott","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.11.008_b0025","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/trf.16025","article-title":"Development and performance characteristics of Platelet Virtual Crossmatch (PLT VXM), a software application for the evaluation and management of platelet transfusion-refractory patients","volume":"60","author":"Juskewitch","year":"2020","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.tracli.2024.11.008_b0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/17474086.2021.1924053","article-title":"Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia","volume":"14","author":"Al-Samkari","year":"2021","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.008_b0035","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","article-title":"Platelet transfusion refractoriness","volume":"142","author":"Hod","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2024.11.008_b0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0268-960X(90)90013-I","article-title":"Platelet transfusions: the problem of refractoriness","volume":"4","author":"Murphy","year":"1990","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.008_b0045","first-page":"200","article-title":"Relative importance of immune and non-immune causes of platelet refractoriness","volume":"66","author":"Doughty","year":"1994","journal-title":"Vox Sang"},{"issue":"2","key":"10.1016\/j.tracli.2024.11.008_b0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood.V71.2.383.383","article-title":"Clinical factors influencing the efficacy of pooled platelet transfusions","volume":"71","author":"Bishop","year":"1988","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.tracli.2024.11.008_b0055","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.bbmt.2018.05.006","article-title":"Platelet transfusion refractoriness in single-unit cord blood transplantation for adults: risk factors and clinical outcomes","volume":"24","author":"Tanoue","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.008_b0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.2017.76.1734","article-title":"Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice guideline update","volume":"36","author":"Schiffer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.tracli.2024.11.008_b0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1537-2995.1977.17678075665.x","article-title":"Selection of compatible platelet donors: a prospective evaluation of three cross-matching techniques","volume":"17","author":"Wu","year":"1977","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.tracli.2024.11.008_b0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood.V46.5.743.743","article-title":"Correction of poor platelet transfusion responses with leukocyte-poor HLA-matched platelet concentrates","volume":"46","author":"Herzig","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2024.11.008_b0075","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1111\/trf.15530","article-title":"HLA-matched platelet transfusions are effective only in refractory patients with positive HLA antibody screening","volume":"59","author":"Kreuger","year":"2019","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.008_b0080","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/trf.15108","article-title":"HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience","volume":"59","author":"Karlstr\u00f6m","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.11.008_b0130","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3324\/haematol.2018.189365","article-title":"A subset of anti-HLA antibodies induces Fc\u03b3RIIa-dependent platelet activation","volume":"103","author":"Rijkers","year":"2018","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.tracli.2024.11.008_b0135","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3324\/haematol.2018.201665","article-title":"Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets","volume":"104","author":"Rijkers","year":"2019","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.008_b0085","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jcla.21750","article-title":"Platelet antibody analysis by three different tests","volume":"29","author":"Sareban","year":"2015","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.tracli.2024.11.008_b0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12288-022-01547-9","article-title":"Methodological study on the establishment of HLA\/HPA gene bank of platelet donors and its clinical application","volume":"39","author":"Xu","year":"2023","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"6","key":"10.1016\/j.tracli.2024.11.008_b0095","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/trf.16358","article-title":"Platelet transfusion refractoriness and anti-HLA immunization","volume":"61","author":"Blandin","year":"2021","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.tracli.2024.11.008_b0100","first-page":"1923","article-title":"The effect of immunized platelet transfusion refractoriness on allo-HSCT patients with malignant hematological diseases","volume":"29","author":"Zuo","year":"2021","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.tracli.2024.11.008_b0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00277-017-3168-6","article-title":"Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"97","author":"Solves","year":"2018","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.tracli.2024.11.008_b0140","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/trf.16430","article-title":"Human leukocyte antigen (HLA)-incompatible mean fluorescence intensity-selected platelet products have corrected count increments similar to HLA antigen-matched platelets","volume":"61","author":"Karafin","year":"2021","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.008_b0145","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/trf.15108","article-title":"HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience","volume":"59","author":"Karlstr\u00f6m","year":"2019","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.008_b0150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/trf.15664","article-title":"Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation","volume":"60","author":"Seike","year":"2020","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.tracli.2024.11.008_b0155","first-page":"187","article-title":"Evaluation of platelet cross-matching in the management of patients refractory to platelet transfusions","volume":"12","author":"Salama","year":"2014","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2024.11.008_b0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jca.20273","article-title":"Flow cytometric platelet cross-matching to predict platelet transfusion in acute leukemia","volume":"26","author":"Sayed","year":"2011","journal-title":"J Clin Apher"},{"issue":"2","key":"10.1016\/j.tracli.2024.11.008_b0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.transci.2013.02.001","article-title":"A positive effect of immune suppression on corrected count increment after platelet transfusion at 1 but not at 24h","volume":"49","author":"Dijkstra-Tiekstra","year":"2013","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"10.1016\/j.tracli.2024.11.008_b0170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jama.1980.03300310023016","article-title":"Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations","volume":"243","author":"Daly","year":"1980","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.tracli.2024.11.008_b0175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness-practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Stanworth","year":"2015","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.tracli.2024.11.008_b0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1537-2995.1994.34594249054.x","article-title":"Effect of amphotericin B and fluconazole on platelet membrane glycoproteins","volume":"34","author":"Sloand","year":"1994","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2024.11.008_b0185","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2023.2229905","article-title":"Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases","volume":"34","author":"Song","year":"2023","journal-title":"Platelets"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782024001320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782024001320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:51:36Z","timestamp":1740531096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782024001320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1246782024001320"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2024.11.008","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of HLA-matched platelet units in HLA-immunized PTR: A retrospective study of patients with hematological disorders","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2024.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\ufffdt\ufffd francophone de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}